Tom van der Poll
- The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumoniaBy Marcel Schouten, J. Daan de Boer, Cornelis van ’t Veer, Joris J.T.H. Roelofs, Joost C.M. Meijers, Marcel Levi, Edward M. Conway and Tom van der PollMarcel Schouten*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, AmsterdamJ. Daan de Boer*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, AmsterdamCornelis van ’t Veer*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, AmsterdamJoris J.T.H. Roelofs¶Dept of Pathology, Academic Medical Center, University of Amsterdam, AmsterdamJoost C.M. Meijers+Dept of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, AmsterdamMarcel Levi§Dept of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsEdward M. ConwayfCentre for Blood Research, Life Sciences Institute, Division of Hematology-Oncology, Faculty of Medicine, University of British Columbia, Vancouver, BC, CanadaTom van der Poll*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, Amsterdam#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam§Dept of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responsesBy Liesbeth M. Kager, J. Daan de Boer, Paul Bresser, Jaring S. van der Zee, Sacha Zeerleder, Joost C.M. Meijers, Cornelis van 't Veer and Tom van der PollLiesbeth M. Kager1Center of Experimental and Molecular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam,2Center for Infection and Immunity Amsterdam, Academic Medical Center/University of Amsterdam, AmsterdamJ. Daan de Boer1Center of Experimental and Molecular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam,Paul Bresser3Dept of Pulmonology, Academic Medical Center/University of Amsterdam, Amsterdam4Dept of Pulmonology, Onze Lieve Vrouwe Gasthuis, AmsterdamJaring S. van der Zee3Dept of Pulmonology, Academic Medical Center/University of Amsterdam, Amsterdam4Dept of Pulmonology, Onze Lieve Vrouwe Gasthuis, AmsterdamSacha Zeerleder5Dept of Hematology, Academic Medical Center/University of Amsterdam, Amsterdam6Dept of Immunopathology, Sanquin Research at CLB and Landsteiner Laboratory of the AMC, AmsterdamJoost C.M. Meijers**Dept of Experimental Vascular Medicine, Academic Medical Center/University of Amsterdam, AmsterdamCornelis van 't Veer1Center of Experimental and Molecular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam,2Center for Infection and Immunity Amsterdam, Academic Medical Center/University of Amsterdam, AmsterdamTom van der Poll1Center of Experimental and Molecular Medicine, Academic Medical Center/University of Amsterdam, Amsterdam,2Center for Infection and Immunity Amsterdam, Academic Medical Center/University of Amsterdam, Amsterdam8Division of Infectious Diseases, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands
- Increased incidence of pulmonary embolism in severe asthmaBy Christof Majoor, Pieter Kamphuisen, Lous Rijssenbeek-Nouwens, Tom van der Poll, Aelko Zwinderman, Peter Sterk, Harry Büller and Elisabeth BelChristof Majoor1Department of Pulmonology, Academic Medical Centre, Amsterdam, NetherlandsPieter Kamphuisen2Department of Vascular Medicine, Academic Medical Centre, Amsterdam, NetherlandsLous Rijssenbeek-Nouwens3Department of Pulmonology, Netherlands Asthmacenter Davos, Davos Wolfgang, SwitzerlandTom van der Poll4Center for Experimental and Molecular Medicine, Academic Medical Centre, Amsterdam, NetherlandsAelko Zwinderman5Department of Medical Statistics, Clinical Epidemiology and Biostatistics, Academic Medical Centre, Amsterdam, NetherlandsPeter Sterk1Department of Pulmonology, Academic Medical Centre, Amsterdam, NetherlandsHarry Büller2Department of Vascular Medicine, Academic Medical Centre, Amsterdam, NetherlandsElisabeth Bel1Department of Pulmonology, Academic Medical Centre, Amsterdam, Netherlands
- Rhinovirus infection activates coagulation through eosinophilic airway inflammationBy Christof Majoor, Pieter Kamphuisen, Marianne van de Pol, Joost Meijers, Tom van der Poll, Anita Böing, Rienk Nieuwland, Sebastian Johnston, Peter J. Sterk, Elisabeth Bel, René Lutter and Koen van der SluijsChristof Majoor1Respiratory Medicine, Academic Medical Center, Amsterdam, NetherlandsPieter Kamphuisen7Vascular Medicine, University Medical Center, Groningen, NetherlandsMarianne van de Pol2Experimental Immunology, Academic Medical Center, Amsterdam, NetherlandsJoost Meijers3Experimental Vascular Medicine, Academic Medical Center, Amsterdam, NetherlandsTom van der Poll5Center of Experimental and Molecular Medicine, Academic Medical Center, Amsterdam, NetherlandsAnita Böing4Experimental Clinical Chemistry, Academic Medical Center, Amsterdam, NetherlandsRienk Nieuwland4Experimental Clinical Chemistry, Academic Medical Center, Amsterdam, NetherlandsSebastian Johnston8Respiratory Medicine, National Heart and Lung Institute, Imperial College, London, United KingdomPeter J. Sterk1Respiratory Medicine, Academic Medical Center, Amsterdam, NetherlandsElisabeth Bel1Respiratory Medicine, Academic Medical Center, Amsterdam, NetherlandsRené Lutter2Experimental Immunology, Academic Medical Center, Amsterdam, NetherlandsKoen van der Sluijs6Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, Amsterdam, Netherlands
- Local coagulation activation following bronchial instillation of house dust mite allergen (HDM) and HDM/Lipopolysaccharide (LPS) in mild asthmaticsBy Marieke Berger, Johannes D. de Boer, Tom van der Poll, Peter J. Sterk and Jaring S. van der ZeeMarieke Berger1Respiratory Diseases, Academic Medical Center, University of Amsterdam, NetherlandsJohannes D. de Boer2Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, NetherlandsTom van der Poll2Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, NetherlandsPeter J. Sterk1Respiratory Diseases, Academic Medical Center, University of Amsterdam, NetherlandsJaring S. van der Zee1Respiratory Diseases, Academic Medical Center, University of Amsterdam, Netherlands
- The lectin-like domain of thrombomodulin hampers host defense in pneumococcal pneumoniaBy Marcel Schouten, J. Daan de Boer, Cornelis van ‘t Veer, Joris J. T. H. Roelofs, Joost C. M. Meijers, Marcel Levi, Edward M. Conway and Tom van der PollArticle | Published in 2012 in European Respiratory JournalMarcel Schouten*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsJ. Daan de Boer*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsCornelis van ‘t Veer*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsJoris J. T. H. Roelofs¶Dept of Pathology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsJoost C. M. Meijers+Dept of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsMarcel Levi§Dept of Internal Medicine; Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsEdward M. ConwayfCentre for Blood Research, Life Sciences Institute, Division of Hematology-Oncology, Faculty of Medicine, University of British Columbia, Vancouver, CanadaTom van der Poll*Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands#Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands§Dept of Internal Medicine; Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
- Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responsesBy Liesbeth M. Kager, J. Daan de Boer, Paul Bresser, Jaring S. van der Zee, Sacha Zeerleder, Joost C. M. Meijers, Cornelis van 't Veer and Tom van der PollArticle | Published in 2012 in European Respiratory JournalLiesbeth M. Kager*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular Medicine#Academic Medical Center/University of Amsterdam, The Netherlands, Center for Infection and Immunity AmsterdamJ. Daan de Boer*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular MedicinePaul Bresser¶Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Pulmonology**Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands, Dept of Pulmonology, Sanquin Research at CLB and Landsteiner Laboratory of the AMC, Amsterdam, The NetherlandsJaring S. van der Zee¶Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Pulmonology**Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands, Dept of Pulmonology, Sanquin Research at CLB and Landsteiner Laboratory of the AMC, Amsterdam, The NetherlandsSacha Zeerleder+Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Hematology##Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands, Dept of ImmunopathologyJoost C. M. Meijers§Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Experimental Vascular MedicineCornelis van 't Veer*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular Medicine#Academic Medical Center/University of Amsterdam, The Netherlands, Center for Infection and Immunity AmsterdamTom van der Poll*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular Medicine#Academic Medical Center/University of Amsterdam, The Netherlands, Center for Infection and Immunity AmsterdamfAcademic Medical Center/University of Amsterdam, The Netherlands, Division of Infectious Diseases
- Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responsesBy Liesbeth M. Kager, J.D. De Boer, Paul Bresser, Jaring S. van der Zee, Sacha Zeerleder, Joost C. M. Meijers, Cornelis van 't Veer and Tom van der PollArticle | Published in 2012 in European Respiratory JournalLiesbeth M. Kager*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular Medicine#Academic Medical Center/University of Amsterdam, The Netherlands, Center for Infection and Immunity AmsterdamJ.D. De Boer*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular MedicinePaul Bresser¶Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Pulmonology**Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands, Dept of Pulmonology, Sanquin Research at CLB and Landsteiner Laboratory of the AMC, Amsterdam, The NetherlandsJaring S. van der Zee¶Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Pulmonology**Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands, Dept of Pulmonology, Sanquin Research at CLB and Landsteiner Laboratory of the AMC, Amsterdam, The NetherlandsSacha Zeerleder+Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Hematology##Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands, Dept of ImmunopathologyJoost C. M. Meijers§Academic Medical Center/University of Amsterdam, The Netherlands, Dept of Experimental Vascular MedicineCornelis van 't Veer*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular Medicine#Academic Medical Center/University of Amsterdam, The Netherlands, Center for Infection and Immunity AmsterdamTom van der Poll*Academic Medical Center/University of Amsterdam, The Netherlands, Center of Experimental and Molecular Medicine#Academic Medical Center/University of Amsterdam, The Netherlands, Center for Infection and Immunity AmsterdamfAcademic Medical Center/University of Amsterdam, The Netherlands, Division of Infectious Diseases
- Myeloid-related protein-14 deficiency promotes inflammation in staphylococcal pneumoniaBy Ahmed Achouiti, Thomas Vogl, Anne J. Van der Meer, Ingrid Stroo, Sandrine Florquin, Onno J. de Boer, Johannes Roth, Sacha Zeerleder, Cornelis van ’t Veer, Alex F. de Vos and Tom van der PollArticle | Published in 2015 in European Respiratory JournalAhmed Achouiti1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsThomas Vogl3Institute of Immunology, University of Munster, Munster, GermanyAnne J. Van der Meer1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsIngrid Stroo1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsSandrine Florquin4Dept of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsOnno J. de Boer4Dept of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsJohannes Roth3Institute of Immunology, University of Munster, Munster, GermanySacha Zeerleder5Dept of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands6Dept of Immunopathology, Sanquin Research, Amsterdam, The NetherlandsCornelis van ’t Veer1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsAlex F. de Vos1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsTom van der Poll1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands7Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Myeloid-related protein-14 deficiency promotes inflammation in staphylococcal pneumoniaBy Ahmed Achouiti, Thomas Vogl, Anne J. Van der Meer, Ingrid Stroo, Sandrine Florquin, Onno J. de Boer, Johannes Roth, Sacha Zeerleder, Cornelis van ’t Veer, Alex F. de Vos and Tom van der PollAhmed Achouiti1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsThomas Vogl3Institute of Immunology, University of Munster, Munster, GermanyAnne J. Van der Meer1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsIngrid Stroo1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsSandrine Florquin4Dept of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsOnno J. de Boer4Dept of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsJohannes Roth3Institute of Immunology, University of Munster, Munster, GermanySacha Zeerleder5Dept of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands6Dept of Immunopathology, Sanquin Research, Amsterdam, The NetherlandsCornelis van ’t Veer1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsAlex F. de Vos1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsTom van der Poll1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands2Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands7Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Activated protein C inhibits neutrophil migration in allergic asthma: a randomised trialBy J. Daan de Boer, Marieke Berger, Christof J. Majoor, Liesbeth M. Kager, Joost C.M. Meijers, Sanne Terpstra, Rienk Nieuwland, Anita N. Boing, René Lutter, Diana Wouters, Gerard J. van Mierlo, Sacha S. Zeerleder, Elisabeth H. Bel, Cornelis van't Veer, Alex F. de Vos, Jaring S. van der Zee and Tom van der PollArticle | Published in 2015 in European Respiratory JournalJ. Daan de Boer1Center of Infection and Immunity Amsterdam, and Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsMarieke Berger2Dept of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands11These authors contributed equally to this workChristof J. Majoor2Dept of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands11These authors contributed equally to this workLiesbeth M. Kager1Center of Infection and Immunity Amsterdam, and Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsJoost C.M. Meijers3Dept of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands4Dept of Plasma Proteins, Sanquin, Amsterdam, the NetherlandsSanne Terpstra1Center of Infection and Immunity Amsterdam, and Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsRienk Nieuwland5Dept of Clinical Chemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsAnita N. Boing5Dept of Clinical Chemistry, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsRené Lutter2Dept of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands6Dept of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsDiana Wouters7Dept of Immunopathology, Sanquin, Amsterdam, the NetherlandsGerard J. van Mierlo7Dept of Immunopathology, Sanquin, Amsterdam, the NetherlandsSacha S. Zeerleder7Dept of Immunopathology, Sanquin, Amsterdam, the Netherlands8Dept of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsElisabeth H. Bel2Dept of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsCornelis van't Veer1Center of Infection and Immunity Amsterdam, and Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsAlex F. de Vos1Center of Infection and Immunity Amsterdam, and Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the NetherlandsJaring S. van der Zee9Dept of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the NetherlandsTom van der Poll1Center of Infection and Immunity Amsterdam, and Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands10Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
- Coagulation activity increases with disease severity in patients with asthmaBy Marlous Sneeboer, Christof Majoor, Anne De Kievit, Joost Meijers, Rene Lutter, Tom Van der Poll, Pieter-Willem Kamphuisen, Peter Sterk and Elisabeth BelMarlous Sneeboer1Department of Respiratory Medicine, Academic Medical Center Amsterdam, Amsterdam, NetherlandsChristof Majoor1Department of Respiratory Medicine, Academic Medical Center Amsterdam, Amsterdam, NetherlandsAnne De Kievit1Department of Respiratory Medicine, Academic Medical Center Amsterdam, Amsterdam, NetherlandsJoost Meijers2Department of Experimental Vascular Medicine, Academic Medical Center Amsterdam, Amsterdam, NetherlandsRene Lutter3Department of Respiratory Medicine and Experimental Immunology, Academic Medical Center Amsterdam, Amsterdam, NetherlandsTom Van der Poll4Center of Experimental and Molecular Medicine, Academic Medical Center Amsterdam, Amsterdam, NetherlandsPieter-Willem Kamphuisen5Department of Vascular Medicine, University Medical Center Groningen, Groningen, NetherlandsPeter Sterk1Department of Respiratory Medicine, Academic Medical Center Amsterdam, Amsterdam, NetherlandsElisabeth Bel1Department of Respiratory Medicine, Academic Medical Center Amsterdam, Amsterdam, Netherlands
- Effect of a 10-day oral corticosteroid course on hemostasis and inflammation in patients with stable asthmaBy Christof Majoor, Marlous Sneeboer, Anne De Kievit, Joost Meijers, Tom Van der Poll, Rene Lutter, Pieter Willem Kamphuisen and Elisabeth BelChristof Majoor1Respiratory Medicine, Academic Medical Centre, Amsterdam, NetherlandsMarlous Sneeboer1Respiratory Medicine, Academic Medical Centre, Amsterdam, NetherlandsAnne De Kievit1Respiratory Medicine, Academic Medical Centre, Amsterdam, NetherlandsJoost Meijers3Experimanetal Vascular Medicine, Academic Medical Centre, Amsterdam, Netherlands4Plasma Proteins, Sanquin Research, Amsterdam, NetherlandsTom Van der Poll5Center of Experimental and Molecular Medicine, Academic Medical Centre, Amsterdam, NetherlandsRene Lutter1Respiratory Medicine, Academic Medical Centre, Amsterdam, Netherlands2Experimental Immunology, Academic Medical Centre, Amsterdam, NetherlandsPieter Willem Kamphuisen6Vascular Medicne, University Medical Centre Groningen, Groningen, NetherlandsElisabeth Bel1Respiratory Medicine, Academic Medical Centre, Amsterdam, Netherlands
- The temporal stability of coagulation and fibrinolytic factors in patients with asthma and healthy subjectsBy Anne De Kievit, Marlous Sneeboer, Christof Majoor, Joost Meijers, Rene Lutter, Tom Van der Poll, Pieter-Willem Kamphuisen, Peter Sterk and Elisabeth BelAnne De Kievit1Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsMarlous Sneeboer1Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsChristof Majoor1Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsJoost Meijers2Department of Experimental Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsRene Lutter1Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands3Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsTom Van der Poll4Center of Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsPieter-Willem Kamphuisen5Department of Vascular Medicine, University Medical Center Groningen, Groningen, NetherlandsPeter Sterk1Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsElisabeth Bel1Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.